The risk of blood clots forming and hence the need to use life long anti-coagulants is the recognised main draw back of current MHV..
The current bi-leaflet design is certainly superior in its design to the early MHV.
However, I've just scanned the internet and noticed that 5-10 years ago research and testing was being carried out on a further improvement..the tri-leaflet MHV that more accurately mimics a native heart valve, and has the potential for no long term anticoagulant treatment.
Does anyone know how this research is progressing and whether the next generation of MHV, the tri-leaflet is to be used on human patients anytime soon ??
The current bi-leaflet design is certainly superior in its design to the early MHV.
However, I've just scanned the internet and noticed that 5-10 years ago research and testing was being carried out on a further improvement..the tri-leaflet MHV that more accurately mimics a native heart valve, and has the potential for no long term anticoagulant treatment.
Does anyone know how this research is progressing and whether the next generation of MHV, the tri-leaflet is to be used on human patients anytime soon ??